ScanSource delivered one of the more lopsided quarters of the season. Fiscal first-quarter revenue jumped 30.1% year over year to $962.29 million, beating the $859.5 million consensus by 12.0%. Non-GAAP earnings, however, came in at just $0.86 per share, well short of the $1.12 consensus and the $1.19 Earnings Whisper number. That is a 27.7% miss, and earnings fell 18.9% from a year ago. That is the central tension. Top-line growth has accelerated for four straight quarters, from roughly 3% to 9% to 17% to 30%, yet almost none of that volume reached the bottom line. Non-GAAP EPS fell from a record $1.46 in the fiscal fourth quarter to $0.86.

The quality of the quarter deserves scrutiny. Gross margin dropped 238 basis points to 12.2%, which management attributed to strong hardware demand and a heavier mix of lower-margin large deals. In Specialty Technology Solutions, gross profit grew only 3% on 28% sales growth. Segment adjusted EBITDA margin fell to 2.18% from 3.96% in the prior quarter. Consolidated adjusted EBITDA declined 18.9% to $31.3 million, a 3.25% margin versus 5.22% a year ago. About $4.5 million of higher bad-debt expense, tied mainly to Oi, a former Brazilian telecom giant now in judicial proceedings, cost roughly $0.16 per share. Even with that hit set aside, results would still have trailed consensus, so the miss cannot be blamed on Brazil alone. GAAP EPS fell to $0.42 from $0.89, weighed further by $4.4 million in acquisition costs and $1.7 million in restructuring charges.

The call shows a business winning volume but struggling to monetize it. Management cited broad North American strength in security, Cisco networking, barcode/mobility and communications hardware. Large deals that had been pushed out or split up previously closed in the quarter. Organic growth was still about 27%. However, management acknowledged that pricing contributed a 'fair amount' of that growth without quantifying it, which leaves its durability uncertain. Brazil sales fell 20.5% in constant currency. The higher-margin agency side remains sluggish: organic Intelisys & Solution Services growth was 3.2%, and net billings rose only 3.8% to about $2.9 billion. Recurring revenue grew 15.7% and lifted its share of gross profit to 32.8%, but it is too small to offset hardware mix.

The guidance raise is less generous than it looks. Fiscal 2027 net sales guidance is now $3.8 billion to $4.0 billion, and adjusted EBITDA guidance rose to $175 million to $185 million from $158 million to $165 million. Both figures now include MicroAge, which closed September 1. The CFO put MicroAge's 10-month EBITDA contribution near $20 million and said organic expectations for the remaining three quarters are unchanged. Adding MicroAge to the prior range implies the organic low end slipped by roughly $3 million. Free cash flow guidance was held at 'at least $85 million' rather than raised. That target now requires a sharp reversal from the first quarter's $44.1 million cash burn, which was driven by working capital.

The balance sheet has also changed character. Cash fell to $45.9 million from $88.4 million, and $231.9 million was drawn on the revolver to fund the roughly $218 million acquisition. Net leverage moved to about 2x adjusted EBITDA from near zero. Annualized adjusted ROIC dropped to 10.7% from 14.6% a year earlier, and the receivables allowance climbed to $33.4 million from $26.6 million.

There are real catalysts:

• MicroAge adds cloud, cybersecurity, data center and AI capabilities, and a pilot to co-sell its managed services through ScanSource's channel partners is launching.
• Management sees share-gain potential from TD Synnex's acquisition of competitor Blue Star.

Offsetting those, the Juniper ramp has slipped again, with revenue now expected only in the second half of fiscal 2027.

Investors were already turning cautious before the report. Earnings Whispers sentiment swung from roughly neutral (0.04) to clearly negative (-0.21), a meaningful deterioration. The stock entered earnings at $56.98, down 12.1% since the open after the August report. That leaves it 14.7% below the $66.78 52-week high set on August 20 and only 6.7% above its inter-earnings low. Shares still sit about 18.6% above the 200-day moving average, so the longer-term uptrend has not been broken. Even so, the market had clearly been unwinding the post-August enthusiasm, and this report gives bears legitimate ammunition.

The bottom line is that ScanSource proved demand is robust but not that the growth is profitable. Revenue acceleration is genuine, yet margins compressed sharply, earnings missed by a wide margin, cash flow turned negative and leverage rose. The headline guidance raise is essentially acquired EBITDA layered on a slightly softer organic base. Until gross profit growth starts tracking sales and working capital reverses, the 30% top line is more a question about pricing and mix than a validation of the earnings story.